GO:0070039 rRNA (guanosine-2'-O-ribose)-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070039 describes the enzymatic activity that transfers a methyl group from S-adenosyl-L-methionine to the 2'-O position of guanosine in ribosomal RNA, producing 2'-O-methylguanosine and S-adenosyl-L-homocysteine.
• This modification is catalyzed by fibrillarin (FBL) in eukaryotes and by related methyltransferases in archaea and bacteria, often as part of box C/D small nucleolar ribonucleoprotein complexes.
• 2'-O-methylation of rRNA is critical for ribosome assembly, stability, and translational fidelity, and its dysregulation has been linked to cancer and developmental disorders.
• The activity is highly conserved and can be studied using radiolabeled SAM, mass spectrometry, and CRISPR-based knockout models.
• Mutations in the catalytic domain of FBL or its guide RNAs can abolish 2'-O-methylation, affecting ribosome function and cellular stress responses.
• Targeting rRNA methyltransferases is an emerging therapeutic strategy in oncology, with small-molecule inhibitors under investigation.
Description
Ribosomal RNA (rRNA) is extensively modified post-transcriptionally, and one of the most common modifications is 2'-O-methylation of ribose sugars. The enzyme activity responsible for adding a methyl group to the 2'-O position of guanosine in rRNA is classified as GO:0070039, rRNA (guanosine-2'-O-ribose)-methyltransferase activity. This activity uses S-adenosyl-L-methionine (SAM) as the methyl donor and produces S-adenosyl-L-homocysteine (SAH) as a byproduct, thereby modifying the rRNA backbone and influencing ribosome structure and function. Researchers study this activity because it is essential for ribosome biogenesis, translational accuracy, and cellular responses to stress, and because its dysregulation is increasingly implicated in human diseases such as cancer and ribosomopathies.
rRNA (guanosine-2'-O-ribose)-methyltransferase activity At A Glance
| GO ID | GO:0070039 |
|---|---|
| GO term | rRNA (guanosine-2'-O-ribose)-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | rRNA (guanosine-2'-O-)-methyltransferase activity |
| Definition | Catalysis of the reaction: S-adenosyl-L-methionine + rRNA = S-adenosyl-L-homocysteine + rRNA containing 2'-O-methylguanosine. |
| Major function | Methylation of the 2'-O position of guanosine in rRNA, affecting ribosome assembly and function. |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor. |
| Localization | Nucleolus in eukaryotes, often within box C/D snoRNP complexes. |
| Representative enzyme | Fibrillarin (FBL) in eukaryotes; homologs in archaea and bacteria. |
What Is GO:0070039?
According to the Gene Ontology, GO:0070039 is defined as the catalysis of the reaction: S-adenosyl-L-methionine + rRNA = S-adenosyl-L-homocysteine + rRNA containing 2'-O-methylguanosine. In other words, it is the enzymatic activity that methylates the 2'-hydroxyl group of a guanosine nucleotide within an rRNA molecule, using SAM as the methyl donor.
Why Is rRNA (guanosine-2'-O-ribose)-methyltransferase activity Important in Cell Biology?
The 2'-O-methylation of rRNA guanosine is a conserved and abundant modification that stabilizes rRNA structure, facilitates ribosome assembly, and ensures translational fidelity. Because ribosomes are central to protein synthesis, changes in this modification can have profound effects on cell growth, proliferation, and stress responses. Moreover, mutations or altered expression of the enzymes catalyzing this activity have been linked to cancer, developmental defects, and viral replication, making it a target of intense research.
• Essential for ribosome biogenesis and function: 2'-O-methylation of rRNA is required for proper folding and assembly of ribosomal subunits.
• Influences translational fidelity: modification affects codon recognition and peptide bond formation.
• Linked to cancer: overexpression of rRNA methyltransferases such as FBL is observed in multiple cancers and correlates with poor prognosis.
• Implicated in ribosomopathies: defects in rRNA modification can cause developmental disorders like dyskeratosis congenita.
• Target for antiviral therapy: some viruses hijack host methylation machinery, and inhibitors are being explored.
• Regulated by cellular stress: nutrient deprivation and mTOR signaling alter rRNA methylation patterns.
• Conserved across evolution: from archaea to humans, highlighting fundamental importance.
• Potential biomarker: altered 2'-O-methylation patterns are detectable in cancer cells and may serve as diagnostic markers.
Molecular Mechanism of rRNA (guanosine-2'-O-ribose)-methyltransferase activity
Substrate Recognition and Binding
In simple terms: The enzyme finds the specific guanosine in rRNA that needs to be methylated.
The methyltransferase recognizes its target guanosine within the rRNA sequence, often guided by box C/D small nucleolar RNAs (snoRNAs) that base-pair with the rRNA and position the enzyme for catalysis. In eukaryotes, fibrillarin (FBL) is the catalytic component of the box C/D snoRNP complex, which includes NOP56, NOP58, and 15.5K proteins.
Methyl Group Transfer
In simple terms: The enzyme takes a methyl group from SAM and attaches it to the 2'-O position of guanosine.
The catalytic mechanism involves nucleophilic attack of the 2'-hydroxyl group of guanosine on the methyl group of S-adenosyl-L-methionine (SAM), resulting in the formation of 2'-O-methylguanosine and S-adenosyl-L-homocysteine (SAH). This reaction is dependent on a conserved catalytic tetrad of amino acids in the methyltransferase domain.
Cofactor and Metal Ion Requirements
In simple terms: The enzyme needs SAM as a methyl donor and may require metal ions for stability.
SAM is the universal methyl donor for all methyltransferases, including rRNA (guanosine-2'-O-ribose)-methyltransferase. Some homologs require divalent metal ions such as Mg2+ for optimal activity, although the exact requirement varies among species.
Regulation by Cellular Signals
In simple terms: The activity can be turned up or down by cellular signals like nutrient availability.
rRNA methylation is regulated in response to cellular stress and growth signals. For example, mTOR signaling promotes ribosome biogenesis and may indirectly enhance rRNA methylation by increasing expression of methyltransferases. Conversely, nutrient deprivation can reduce methylation levels.
Integration with Ribosome Assembly
In simple terms: The methylation happens while the ribosome is being built, helping it fold correctly.
2'-O-methylation occurs co-transcriptionally during pre-rRNA processing and is coupled with ribosome assembly. The modification stabilizes rRNA structure and facilitates the binding of ribosomal proteins and assembly factors. Disruption of this activity leads to defective ribosome subunits and impaired translation.
Key Genes Involved in GO:0070039 rRNA (guanosine-2'-O-ribose)-methyltransferase activity
The following genes encode enzymes or associated factors that carry out or regulate rRNA (guanosine-2'-O-ribose)-methyltransferase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FBL | Catalytic subunit of box C/D snoRNP; performs 2'-O-methylation of rRNA | Knockout causes loss of methylation and ribosome assembly defects |
| NOP56 | Core box C/D snoRNP protein; essential for snoRNA stability and methylation | Mutations linked to spinocerebellar ataxia |
| NOP58 | Core box C/D snoRNP protein; required for snoRNP assembly | Depletion affects rRNA methylation and ribosome biogenesis |
| 15.5K (SNU13) | RNA-binding protein in box C/D snoRNP; facilitates snoRNA folding | Mutations impair snoRNP function |
| DIMT1 | Methyltransferase that generates N2,N2-dimethylguanosine in rRNA | Knockout affects small RNA processing and ribosome function |
| METTL16 | m6A methyltransferase with roles in rRNA and snRNA methylation | Linked to cancer and RNA processing |
| NSUN family | m5C RNA methyltransferases including rRNA modification | Regulate stem cell function and differentiation |
| FTSJ3 | 2'-O-methyltransferase for 18S rRNA | Required for ribosome biogenesis and innate immunity |
| MRM1 | Mitochondrial rRNA methyltransferase | Mutations cause mitochondrial dysfunction |
| MRM2 | Mitochondrial 2'-O-methyltransferase for 16S rRNA | Defects associated with mitochondrial diseases |
| MRM3 | Mitochondrial rRNA methyltransferase | Knockout impairs mitochondrial translation |
| TGS1 | Trimethylguanosine synthase; also has 2'-O-methyltransferase activity | Involved in snRNA and rRNA modification |
| NAT10 | RNA acetyltransferase that also influences rRNA methylation | Linked to cancer and ribosome biogenesis |
| FMR1 | RNA-binding protein; interacts with ribosome and methylation machinery | Loss causes fragile X syndrome |
| SMN1 | Survival motor neuron protein; involved in snoRNP assembly | Defects cause spinal muscular atrophy |
| DKC1 | Dyskerin; pseudouridine synthase in box H/ACA snoRNP | Mutations cause dyskeratosis congenita |
| GAR1 | Box H/ACA snoRNP protein; interacts with dyskerin | Mutations linked to dyskeratosis congenita |
How Is rRNA (guanosine-2'-O-ribose)-methyltransferase activity Regulated?
The activity of rRNA (guanosine-2'-O-ribose)-methyltransferase is regulated at multiple levels. Transcription of the genes encoding the enzymes, such as FBL, is controlled by growth-promoting transcription factors like MYC and mTOR downstream effectors. Additionally, the assembly and stability of box C/D snoRNP complexes are regulated by chaperones and post-translational modifications. Cellular stress, including nutrient deprivation and DNA damage, can alter rRNA methylation patterns, partly through changes in SAM availability and methyltransferase expression. Furthermore, small molecule inhibitors and metabolic intermediates can modulate enzyme activity, providing potential therapeutic avenues.
rRNA (guanosine-2'-O-ribose)-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FBL | Cancer (breast, prostate), ribosomopathy | Knockout and overexpression in cancer cell lines; xenograft models |
| DKC1 | Dyskeratosis congenita | Patient-derived iPSCs; knockout in hematopoietic stem cells |
| NOP56 | Spinocerebellar ataxia | Knock-in mouse models; neuronal cell lines |
| SMN1 | Spinal muscular atrophy | Knockout mice; patient fibroblasts |
| FTSJ3 | Innate immunity, cancer | Knockout in immune cells; viral infection models |
Cancer
Dysregulation of rRNA methylation is increasingly recognized in cancer. Overexpression of FBL and other rRNA methyltransferases is observed in breast, prostate, and colorectal cancers, and correlates with poor prognosis. Inhibiting these enzymes reduces cancer cell proliferation and induces apoptosis, suggesting they are potential therapeutic targets. For example, small molecule inhibitors of FBL have shown anti-tumor activity in preclinical models.
Ribosomopathies and Developmental Disorders
Mutations in genes encoding rRNA modification enzymes or snoRNP components cause ribosomopathies such as dyskeratosis congenita and cartilage-hair hypoplasia. These disorders are characterized by bone marrow failure, developmental defects, and increased cancer predisposition. Defective 2'-O-methylation leads to ribosome assembly defects and impaired translation, contributing to disease pathology.
Neurodegeneration
Emerging evidence links altered rRNA methylation to neurodegenerative diseases. For instance, mutations in FBL and related genes have been associated with spinocerebellar ataxia and motor neuron diseases. The exact mechanisms are under investigation, but impaired ribosome function in neurons is thought to play a role.
Viral Infections
Some viruses exploit host rRNA methylation machinery to enhance their replication. For example, plant virus satellite RNAs require fibrillarin for systemic trafficking, and inhibition of methylation reduces viral spread. This highlights the potential of targeting rRNA methyltransferases as antiviral strategy.
From rRNA (guanosine-2'-O-ribose)-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of FBL loss on rRNA methylation and translation? | FBL knockout cell lines (e.g., HEK293T, HeLa) |
| How does a specific point mutation in the catalytic domain affect enzyme activity? | Point mutation knock-in via CRISPR in cell lines |
| Can overexpression of FBL drive tumorigenesis? | FBL overexpression in cancer cell lines and mouse xenografts |
| What is the role of FBL in viral replication? | FBL knockout in plant or mammalian cells infected with virus |
| How does DIMT1-mediated methylation affect small RNA processing? | DIMT1 knockout and rescue with wild-type or mutant |
| What are the interactors of box C/D snoRNP complexes? | Tagged knock-in of FBL or NOP56 for affinity purification |
How to Study the rRNA (guanosine-2'-O-ribose)-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| SAM incorporation assay | Methyltransferase activity in vitro | Enzyme kinetics and inhibitor screening |
| LC-MS/MS | Global 2'-O-methylation levels and sites | Mapping modifications in rRNA |
| RTL-P | Site-specific 2'-O-methylation | Detection at single-nucleotide resolution |
| Ribo-seq | Translational efficiency and ribosome occupancy | Assessing impact on protein synthesis |
| Polysome profiling | Distribution of ribosomes on mRNAs | Global translation analysis |
| AP-MS | Protein-protein interactions | Identifying snoRNP components |
| CRISPR knockout screen | Genes required for methylation | Functional genomics |
| CRISPRi/a | Gene expression modulation | Studying dosage effects |
Detection of 2'-O-Methylation
Several methods are used to detect and quantify 2'-O-methylation of rRNA. These include radiolabeled SAM incorporation assays, which measure methyltransferase activity in vitro. Mass spectrometry-based approaches, such as LC-MS/MS, can map methylation sites with high precision. Additionally, site-specific methods like RTL-P (reverse transcription at low dNTP concentrations followed by PCR) exploit the resistance of 2'-O-methylated nucleotides to reverse transcription, allowing detection at specific positions.
Ribosome Profiling and Translation Assays
Ribo-seq (ribosome profiling) provides a snapshot of translation by sequencing ribosome-protected mRNA fragments. It can reveal changes in translational efficiency upon modulation of rRNA methylation. Polysome profiling and puromycin incorporation assays are also used to assess global translation rates.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) is used to identify protein interactors of rRNA methyltransferases and snoRNP components. Proximity labeling techniques like BioID can map the spatial organization of the methylation machinery in living cells.
CRISPR-Based Functional Genomics
CRISPR knockout screens can identify genes required for rRNA methylation and ribosome function. For example, a genome-wide knockout screen using a methylation-sensitive reporter can uncover novel regulators. CRISPR interference (CRISPRi) and activation (CRISPRa) allow fine-tuning of gene expression to study dosage effects.
How CRISPR Can Be Used to Study GO:0070039 rRNA (guanosine-2'-O-ribose)-methyltransferase activity
Knockout
CRISPR knockout of FBL or other rRNA methyltransferases completely abolishes the corresponding 2'-O-methylation activity, leading to defective ribosome assembly and impaired translation. Knockout cell lines are valuable for studying the cellular consequences of loss of methylation, including effects on proliferation, stress responses, and gene expression.
Point Mutation
Introducing specific point mutations in the catalytic domain of FBL (e.g., in the conserved tetrad) via CRISPR knock-in allows researchers to dissect the enzymatic mechanism and separate catalytic activity from structural roles. Such models can reveal whether methylation is required for specific functions, such as ribosome assembly versus translation fidelity.
Knock-in
Knock-in of tagged versions of FBL (e.g., FLAG, HA, or GFP) enables affinity purification and imaging of the methyltransferase complex in its native context. This approach is useful for identifying interacting partners and tracking subcellular localization.
Overexpression
Overexpression of wild-type or mutant FBL using CRISPR activation or lentiviral vectors can model the elevated methylation observed in cancer. Such models help determine whether increased methylation drives oncogenesis and can be used to test targeted inhibitors.
How EDITGENE Supports rRNA (guanosine-2'-O-ribose)-methyltransferase activity Research
Researchers studying rRNA (guanosine-2'-O-ribose)-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in ribosome function, disease, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for rRNA (guanosine-2'-O-ribose)-methyltransferase activity research.
Frequently Asked Questions About rRNA (guanosine-2'-O-ribose)-methyltransferase activity
What is GO:0070039?
GO:0070039 is the Gene Ontology term for rRNA (guanosine-2'-O-ribose)-methyltransferase activity, the enzyme activity that methylates the 2'-O position of guanosine in rRNA using SAM.
What genes are involved in rRNA (guanosine-2'-O-ribose)-methyltransferase activity?
Key genes include FBL, NOP56, NOP58, SNU13, DIMT1, FTSJ3, and mitochondrial MRM1/2/3.
What diseases are associated with defects in rRNA methylation?
Defects are linked to cancers, ribosomopathies like dyskeratosis congenita, and neurodegenerative disorders.
How can I study rRNA (guanosine-2'-O-ribose)-methyltransferase activity?
Common methods include SAM incorporation assays, LC-MS/MS, RTL-P, and CRISPR knockout models.
What is the role of fibrillarin in rRNA methylation?
Fibrillarin is the catalytic subunit of box C/D snoRNP that performs 2'-O-methylation of rRNA.
Is rRNA methylation conserved across species?
Yes, the activity is conserved from archaea to humans, highlighting its fundamental importance.
Can CRISPR be used to knockout FBL?
Yes, CRISPR knockout of FBL is a powerful approach to study loss of methylation and its cellular effects.
What are the potential therapeutic targets in this pathway?
FBL and other rRNA methyltransferases are being explored as targets for cancer therapy and antiviral drugs.
How does mTOR regulate rRNA methylation?
mTOR signaling promotes ribosome biogenesis and may indirectly enhance rRNA methylation by upregulating methyltransferase expression.
What is the difference between 2'-O-methylation and m6A?
2'-O-methylation modifies the ribose sugar, while m6A modifies the adenine base; both are common RNA modifications with distinct functions.
Conclusion
GO:0070039, rRNA (guanosine-2'-O-ribose)-methyltransferase activity, is a fundamental enzymatic activity that modifies rRNA and ensures proper ribosome function. Its dysregulation is linked to cancer, developmental disorders, and viral infections, making it a compelling target for basic and translational research. Advances in CRISPR technology and analytical methods continue to unravel the complexities of this modification and its role in health and disease.
References
- 1. Oerum S et al.. 2021. A comprehensive review of m6A/m6Am RNA methyltransferase structures.. Nucleic Acids Res 49(13):7239-7255 PMID: 34023900
- 2. Shen H et al.. 2021. Human DIMT1 generates N(2)(6,6)A-dimethylation-containing small RNAs.. J Biol Chem 297(4):101146 PMID: 34473991
- 3. Qi YN et al.. 2023. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting.. J Hematol Oncol 16(1):89 PMID: 37533128
- 4. Ruszkowska A. 2021. METTL16, Methyltransferase-Like Protein 16: Current Insights into Structure and Function.. Int J Mol Sci 22(4) PMID: 33671635
- 5. Chang CH et al.. 2025. Nucleolar fibrillarin methyltransferase regulates systemic trafficking of a plant virus satellite RNA.. Plant Cell 37(10) PMID: 40982556
- 8. Moon J et al.. 2025. NSUN-Mediated m5C RNA Modification in Stem Cell Regulation.. Cells 14(20) PMID: 41148823
